top of page

Consulting

Pharmaceutical consulting

        　   PMDA Consultation 　         

5preliminary consultations
12main consultations

          General consulting          

  • Application package

  • Statistical analysis

  • Protocol planning

  • Non-clinical studies

  • Clinical trial notification

Some Cases Handled in the Past

   Addition of indications for latent diseases   

  • Since the approved drugs were approved more than 20 years ago, we support everything from non-clinical packaging strategy planning, non-clinical CRO selection, development strategy planning to PMDA consultation.

  • Database patient survey conducted due to latent disease

   　 Pediatric indication of allergy drugs　    

  • Comprehensive support for development strategy planning, application package strategy, PMDA preliminary consultation preparation, main consultation preparation, and PTC feasibility study.

  • We also provide calculation support for the entire clinical development cost.

bottom of page